BW Communities

Articles for Healthcare

Sputnik V Soft Launched In Over 50 Cities In India: Dr Reddy's

In a tweet on Monday night, the city-based drug maker said it will strengthen the commercial rollout of Sputnik V in the coming weeks.

Read More
Road To Personalized Medication

Personalized medicine is the tailoring of medical treatment to the individual characteristics of each patient. Knowledge of a patient's genetic profile assists doctors select the proper medication and administer it using specific dosage, creating an overall customized treatment.

Read More
Delta Variant Ripping Around The World At A Scorching Pace, Driving New Spike In Cases, Death: WHO

“Delta is now in more than 104 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide,” he said adding that the world is watching in real-time as the COVID-19 virus continues to change and become more transmissible.

Read More
Zydus Cadila Applies For Emergency Use Nod For COVID-19 Vaccine

An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca (AZN.L) and partner Serum Institute of India's Covishield, Bharat Biotech's Covaxin, and Sputnik V developed by Russia's Gamaleya Institute.

Read More
India's Covaxin Effectively Neutralises Delta Variant Of Covid, Says NIH

Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance a vaccine’s effectiveness.

Read More
Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

Only four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson''s Janssen -- have been approved by the European Medicines Agency (EMA) and only those vaccinated by these vaccines will be given vaccination passports and will be allowed to travel within the EU during the pandemic.

Read More
Glenmark Pharma Gets USFDA Nod For Inhalation Product

Glenmark Pharma said the Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company's North American manufacturing facility based in Monroe, North Carolina, and marks the company's first nebulizer approval.

Read More
Delta Variant 'Greatest Threat' To US' COVID-19 Efforts: Dr Fauci

“This is concerning but expected knowing what we do about how efficiently this variant spreads and by what we saw in the United Kingdom with this variant.

Read More

Subscribe to our newsletter to get updates on our latest news